Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2012
06/27/2012CN102516374A Protein system for tetramycin biosynthesis, gene cluster for coding same
06/27/2012CN102516373A Pneumococcal surface protein A without human homology, purification method and application thereof
06/27/2012CN102516372A A mutated immunoglobulin-binding protein
06/27/2012CN102516371A a mutated immunoglobulin-binding protein
06/27/2012CN102516370A Anti-HIV (human immunodeficiency virus) medicine target and use thereof in pharmacy
06/27/2012CN102516369A Mutant polyhedron and preparation method thereof
06/27/2012CN102516354A Separation method and equipment of protein from starch sugar liquefied solution
06/27/2012CN102516199A Compound and application thereof to sulfanilamide medicament detection
06/27/2012CN102516148A Half antigen and antigen of tenuazonic acid and preparation method and application thereof
06/27/2012CN102512670A Streptococcus pyogenes antigens
06/27/2012CN102512662A Protein containing 36-83 amino acid motifs in Coxsackie B3virus 2B protein and application thereof
06/27/2012CN102512661A Protein containing 1st to 79th sites of amino acid basic sequences in protein 2C of coxsackievirus B3 and application for same
06/27/2012CN102512660A Protein containing 51st to 89th sites of amino acid basic sequences in protein 3A of coxsackievirus B3 and application for same
06/27/2012CN102080079B Preparation method and application of novel antimicrobial peptide Misgurin mutant
06/27/2012CN101928718B Protein trimerization modif and application thereof
06/27/2012CN101921776B Brassica napus disease-resistance related gene BnERF56 and application thereof
06/27/2012CN101921325B Antigen capable of increasing CD4 + CD25 + Foxp3 + regulatory T cells and application thereof
06/27/2012CN101914545B Leucine-rich protein ALM gene of branchiostoma japonicum and application thereof
06/27/2012CN101892244B Oryza officinalis anti-Xanthomonas oryzae major gene Xa3/Xa26-2 and application for improving disease resistance of rice thereof
06/27/2012CN101863976B Preparation method of EV71 virus antibody
06/27/2012CN101838650B Development and applications of new human gene FAMLF in human gene recombination, malignant tumor gene detection and specific monoclonal antibody
06/27/2012CN101830980B Chlorothalonil antigen, antibody preparation method and residual chlorothalonil ELISA (Enzyme-Linked Lmmuno Sorbent Assay) detection method
06/27/2012CN101808668B Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
06/27/2012CN101736012B Stress resistance ERF transcription factor gene derived from Brassica napus
06/27/2012CN101671678B Halimodendron halodendron DREB transcription factor cDNA sequence, expression carrier and application thereof
06/27/2012CN101463086B Diethoxy thiophosphate organophosphorus pesticide antibody, and preparation and use thereof
06/27/2012CN101450966B Polypeptide of antimicrobial agent and use
06/27/2012CN101445554B Wood frog anticancer peptide and preparation method thereof
06/27/2012CN101445552B Rice protein OsOEE3-1, encoding gene and application thereof
06/27/2012CN101392232B Application of dominant suppressing mutant F427D as anthrax bacillus toxin inhibitor and vaccine
06/27/2012CN101374950B Improved IL-15 and IL-15R-alpha for expression in mammalian cells
06/27/2012CN101294964B Reagent and method for detecting active tuberculosis and tuberculosis dormant infection
06/27/2012CN101171262B Glucagon-like-peptide-2 (GLP-2) analogues
06/27/2012CN101107268B Specific binding members for NGF
06/27/2012CN101068935B Genes and polypeptides relating to breast cancers
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8209131 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules
06/26/2012US8207322 Fluorescent protein and chromoprotein
06/26/2012US8207315 Expression vector comprising nucleotide sequence coding angiogenic factor (VG5Q protein) for use in identifying modulators which reduce tumor necrosis factor-like weak inducer of apoptosis (TWEAK) activity and treat or prevent cell proliferative disorders
06/26/2012US8207314 Tumor antigens for prevention and/or treatment of cancer
06/26/2012US8207302 Maize cellulose synthases and uses thereof
06/26/2012US8207301 Hepatocellular carcinoma protein marker
06/26/2012US8207300 CTSP cancer-testis antigens
06/26/2012US8207137 administering a therapeutically effective amount of an active agent selected from the group consisting of a protein substance including all or part of a disintegrin domain of an adamalysin or a derivative thereof
06/26/2012US8207128 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
06/26/2012US8207123 Tumour-specific animal proteins
06/26/2012US8207122 Anti-cancer bioactive peptides isolated from crude venom of Xinjiang Lycosa singoriensis
06/26/2012US8207119 Ophthalmological composition
06/26/2012US8207117 Methods of reducing hemorrhage due to surgical procedure
06/26/2012US8207114 Targeted therapeutic proteins
06/26/2012US8207113 Methods for characterizing glycoproteins and generating antibodies for same
06/26/2012US8207112 Liquid formulation of G-CSF conjugate
06/26/2012US8206989 Method of generating a dosing schedule using gamma secretase notch biomarkers
06/26/2012US8206948 Nucleotide sequences coding sialoglycoprotein-130 (Sgp 130) for use in prevention and treatment of crohn's disease
06/26/2012US8206947 Human transmembrane proteins
06/26/2012US8206938 In vitro methods of detecting cells sensitive to sweet tastants by detecting expression of hetero-oligomeric T1R2/T1R3 taste receptors
06/26/2012US8206937 Tumor suppressor gene p33ING2
06/26/2012US8206899 Prostate cancer-related compositions, methods and kits based on DNA microarray proteomics platforms
06/26/2012US8206750 Charged lipoprotein complexes and their uses
06/26/2012US8206743 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
06/26/2012US8206723 having structurally modified terminal ends which confers enhanced half-life and biological activity for use in prevention and treatment of neuromuscular and pain disorders; cosmetics
06/26/2012US8206719 KDR peptides and vaccines comprising the same
06/26/2012US8206718 Expression and export of angiogenesis inhibitors as immunofusins
06/26/2012US8206713 Method of treating cancer using antibodies to a non-ligand binding region of NOTCH2
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012US8206706 Method for enhancing or inhibiting insulin-like growth factor-I
06/26/2012US8206693 PMMA binding peptides
06/26/2012CA2735129C Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation
06/26/2012CA2605629C Nipah virus vaccines
06/26/2012CA2526950C Method for determining immune system affecting compounds
06/26/2012CA2484594C Process for the synthesis of peptides
06/26/2012CA2462615C Promoters for regulation of gene expression in plant roots
06/26/2012CA2452716C Mammalian sweet and amino acid heterodimeric taste receptors
06/26/2012CA2432474C Fibrin binding polypeptides useful inter alia in medical imaging processes
06/26/2012CA2426952C Small molecule compositions for binding to hsp90
06/26/2012CA2406225C Recombinant intracellular pathogen vaccines and methods for use
06/26/2012CA2405537C Vaccine comprising a tick cement protein
06/26/2012CA2343980C Mammaglobin, a secreted mammary-specific breast cancer protein
06/26/2012CA2323785C Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments
06/26/2012CA2270448C Method for giving resistance to weed control compounds to plants
06/26/2012CA2263895C Therapeutic and diagnostic applications of perlecan domain i splice variants
06/21/2012WO2012083297A2 Adenoviral vectors with modified hexon regions
06/21/2012WO2012083219A1 Combined use of vip3ab and cry1ab for management of resistance insects
06/21/2012WO2012083099A1 Biologically-active radiolabeled cry1fa and receptor binding assay methods
06/21/2012WO2012082933A1 Eluate collection using conductivity gradient
06/21/2012WO2012082891A1 Synthetic peptide inhibitors of wnt pathway
06/21/2012WO2012082325A1 Cry1i proteins and genes for insect control
06/21/2012WO2012082056A1 Novel biomarker and uses thereof in diagnosis, treatment of autism
06/21/2012WO2012081711A1 Cell migration modulator
06/21/2012WO2012081306A1 Test kit for plasma or serum antibody titer against periodontal disease-causing bacteria
06/21/2012WO2012081040A1 Biological activity of placental protein 13
06/21/2012WO2012080844A1 Cell culture medium
06/21/2012WO2012080842A1 Recombinant laminin-521
06/21/2012WO2012080551A1 Cloneable marker for use in microscopy
06/21/2012WO2012080548A1 Bak mutant, associated method for the identification of bak-modulating substances and bak activity inhibiting peptide
06/21/2012WO2012080516A2 Malodour standards and inhibitors
06/21/2012WO2012080510A1 Paralysation of silkworm larvae
06/21/2012WO2012080500A1 Serum amyloid p protein
06/21/2012WO2012080422A1 Method for separating, concentrating or purifying a (blood) plasma protein or viral component from a mixture
06/21/2012WO2012079979A1 Aqueous factor viii solution